Paralysed man stands again after receiving ‘reprogrammed’ stem cells
Another man also regained some movement, but two others experienced minimal improvement. By Smriti Mallapaty Twitter Facebook Email A paralysed man can stand on his own after receiving an injection of neural stem cells to treat his spinal-cord injury. The Japanese man was one of four individuals in a first-of-its-kind trial that used reprogrammed stem […]
Human umbilical cord mesenchymal stem cell-derived exosomes enhance follicular regeneration in androgenetic alopecia via activation of Wnt/β-catenin pathway
Abstract Background Exosomes isolated from human umbilical cord mesenchymal stem cells (hUCMSCs) have demonstrated the capacity to alleviate dihydrotestosterone (DHT)-induced disruptions in the hair follicle growth cycle. However, the precise role and underlying mechanisms by which hUCMSC-derived exosomes influence hair shaft regeneration in androgenetic alopecia (AGA) remains unclear. Methods hUCMSCs were isolated using fluorescence-activated cell […]
Research landscape and trends of human umbilical cord mesenchymal stem cell-derived exosomes
Desheng Chen, Zeping Chen, Jiabin Yuan, Guanzi Chen, Yutao Chen, Kaiming He, Yongwei Hu, Linsen Ye & Yang Yang Stem Cell Research & Therapy volume 16, Article number: 259 (2025) Cite this article 2250 Accesses 1 Citations Metricsdetails Abstract Background Human umbilical cord mesenchymal stem cell-derived exosomes (hUCMSC-Exos) have gained significant attention for their potential […]
FDA Approves First-Ever Cell Therapy Treatment for Rare Progressive Eye Disease
The FDA has approved the first – and only – treatment, a cell therapy, for macular telangiectasia type 2 (MacTel), a rare neurodegenerative disease that causes irreversible vision loss. The treatment, Encelto (revakinagene taroretcel-lwey), is an encapsulated cell therapy, developed by Neurotech Pharmaceuticals, that continually delivers therapeutic doses of ciliary neurotrophic factor to the retina, […]
